Close

Deutsche Bank Initiates Coverage on Omeros Corp (OMER) with a Buy; Emerging Pharmaceutical Company

November 17, 2009 7:31 AM EST Send to a Friend
Deutsche Bank initiates coverage on Omeros Corp (Nasdaq: OMER) with a Buy rating and a $15 price target.

Deutsche analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login